QLT PhotoTherapeutics (QLTI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Michael Anthony who wrote (254)	2/1/1998 3:07:00 PM
From: Michael Anthony	Read Replies (1) of 1321

OK, here it is. Any info regarding ARMD trials that you hear here or from any other source than QLT is false. The study is under extremely tight control, and no information is known regarding phase III at all unless it comes from QLT. Phase III is to be completed next year, but if results are "exceptional", the FDA may speed things up a bit. Bottom line, sit tight and hold on. Hopefully, revenues from the lung cancer treatments will start coming in, but nothing from the ARMD drug will hit the bottom line until probably around late next year or 2000 if it's approved. I was told however, that the QLT study is one of the most organized and well run studies that the MD I spoke with has ever seen. It is a double blind study, so success rates are impossible to determine as you can imagine. Bottom line, ARMD will not bring in any income for quite a while. Wish I could tell you more, but that's all there is and that's the way they want it. I got the impression that QLT is a quality organization, and that alone makes me feel a little more comfortable holding for the next few years.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next